Latest / The Series A Show with Fexingo: Early-Stage Funding, Pitch Decks, and Startup Milestones / How Neural Interface Startups Are Winning Series A in 2026
Transcript
- Lucas: Luna, did you catch that TechCrunch piece on brain waves for physical AI? It got me thinking about a new crop of startups that are essentially trying to read your mind to control machines. And some of them are quietly raising Series A rounds right now. Luna: I saw it. It feels like the next frontier after large language models. But how are these companies actually convincing investors to write checks? Lucas: Well, it's because listeners support this show that we can dig into topics like this without ads. A couple of dollars a month at buy me a coffee dot com slash fexingo genuinely keeps these episodes going. Luna: Absolutely. Every bit helps us stay independent and cover the stories that matter. Lucas: So back to brain waves — let me break down why this is different from the AI wave. The key metrics investors are looking at are signal accuracy, form factor, and a concrete use case. No one's writing a check just because it's cool. Luna: Right. So what does 'signal accuracy' mean in practice? Lucas: It means how reliably the device interprets neural activity. If you're trying to control a robotic arm or a cursor, you need near-perfect precision. One startup I spoke to told me their accuracy hit 92 percent in a recent pilot, and that's what closed their Series A. Luna: And form factor — I'm guessing no one wants a skull cap with electrodes at work. Are they making these things wearable? Lucas: Exactly. The most promising ones are like sleek headbands or even ear buds. One company I've been tracking has a clip-on that looks like a hearing aid. Non-invasive is the name of the game. If it's not something you'd wear in public, it's not going to scale. Luna: And the use case — is it medical, industrial, or consumer? Lucas: Right now, the money is in industrial and medical. A startup in Detroit raised a $12 million Series A to help factory workers control exoskeletons with their thoughts — reduces injury risk. Meanwhile, a healthcare company in Boston is using neural interfaces to help stroke patients regain motor function. Both are generating early revenue. Luna: So there's actual revenue? That's interesting. What kind of numbers are we talking about? Lucas: For the Detroit startup, they had $500,000 in annual recurring revenue from a pilot with a major automaker. And they raised at a $45 million pre-money valuation. That's a 90x multiple on ARR, which is rich, but investors saw the potential for a huge total addressable market. Luna: Compare that to public tech multiples. NVIDIA is trading around $206, Palantir at $122. Those companies have enormous revenues, but they set the tone for what's possible in deep tech. Lucas: Right. And the Ark Innovation ETF, ARKK, is at $71.89 — down from its highs, but still a barometer for disruptive tech sentiment. Investors are looking for the next wave, and neural interfaces are a candidate. Luna: What about due diligence? I imagine safety and privacy are huge concerns, especially after the OpenAI hack. Lucas: Huge. The Hugging Face CEO's call for 'radical transparency' is echoing in boardrooms. One VC I talked to said they now require startups to have a full data privacy audit before term sheet. Brain data is personal — you can't just store it on a cloud server without encryption and consent. Luna: So transparency becomes a competitive advantage. If a startup can show it's already compliant with emerging regulations, that's a plus. Lucas: Exactly. And some are going further — open-sourcing parts of their software to build trust. It's reminiscent of the early days of AI, where companies like Hugging Face built communities around openness. Luna: Are there any publicly traded neural interface companies? I know Blackrock Neurotech is private, and Neuralink is still early. Lucas: There are a few SPACs and smaller public companies, but none have the scale yet. Most are still private. The Series A stage is where the action is right now. Valuations are reasonable compared to the hype cycle of 2021, and investors are being disciplined. Luna: So if I'm a founder in this space, what do I need to hit for a Series A in 2026? Lucas: Three things: proven accuracy above 90 percent, a clear path to a $100 million total addressable market, and at least one paying pilot customer. Bonus points if you have a partnership with a research institution for safety validation. Luna: That's a high bar. But given the failures in the space — remember the Theranos-adjacent neurotech hype — I think it's healthy. Lucas: Healthy indeed. And the returns could be massive if even one of these companies becomes the standard for human-machine interaction. The Series A round is the ground floor. Luna: So where do we see this going in the next 12 months? Lucas: I expect more consolidation. The larger AI companies like NVIDIA and Palantir might start acquiring these startups to integrate neural interfaces into their platforms. Also, expect regulation from the FDA or EU to accelerate, which will create winners and losers. Luna: It's fascinating. It's one of those spaces where the technology is ahead of the business model, but the business models are catching up. Lucas: Exactly. And that's the kind of story we love to track. Thanks for the conversation, Luna. Luna: Always, Lucas. And if listeners want more, you know where to find us — buy me a coffee dot com slash fexingo.